Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Early Feasibility Study of the Neovasc Tiara™ Mitral Transcatheter Heart Valve With the Tiara™ Transapical Delivery System

NCT02276547 is registered in ClinicalTrials.gov with Shockwave Medical, Inc. as lead sponsor.

NCT NCT02276547
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02276547 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Early Feasibility Study of the Neovasc Tiara™ Mitral Transcatheter Heart Valve With the Tiara™ Transapical Delivery System
Lead sponsor
Shockwave Medical, Inc.
Phase
Not applicable
Overall status
Completed
Start date
February 5, 2015
Completion date
December 9, 2024
Enrollment
27 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

mitral valve regurgitation